DK98692D0 - Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof - Google Patents

Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof

Info

Publication number
DK98692D0
DK98692D0 DK92986A DK98692A DK98692D0 DK 98692 D0 DK98692 D0 DK 98692D0 DK 92986 A DK92986 A DK 92986A DK 98692 A DK98692 A DK 98692A DK 98692 D0 DK98692 D0 DK 98692D0
Authority
DK
Denmark
Prior art keywords
cells
new
monoclonal antibody
tumour
producing
Prior art date
Application number
DK92986A
Other languages
English (en)
Other versions
DK98692A (da
DK170423B1 (da
Inventor
Janet H Ransom
Richard P Mccabe
Martin V Haspel
Nicholas Pomato
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK98692D0 publication Critical patent/DK98692D0/da
Publication of DK98692A publication Critical patent/DK98692A/da
Application granted granted Critical
Publication of DK170423B1 publication Critical patent/DK170423B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK098692A 1984-04-13 1992-08-04 Monoklonalt antistof, der er specifikt for leukoregulincelleoverfladereceptorer, og fremgangsmåde til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og prøve for tumorcellefølsomhed under anvendelse af det monoklonale antistof DK170423B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60030384A 1984-04-13 1984-04-13
US60030384 1984-04-13

Publications (3)

Publication Number Publication Date
DK98692D0 true DK98692D0 (da) 1992-08-04
DK98692A DK98692A (da) 1992-08-04
DK170423B1 DK170423B1 (da) 1995-08-28

Family

ID=24403068

Family Applications (2)

Application Number Title Priority Date Filing Date
DK562285A DK170781B1 (da) 1984-04-13 1985-12-04 Human leukoregulin og biologisk aktive underenheder deraf, fremgangsmåde til fremstilling og til oprensning af human leukoregulin, biologisk aktivt materiale indeholdende human leukoregulin samt celle, som producerer human leukoregulin
DK098692A DK170423B1 (da) 1984-04-13 1992-08-04 Monoklonalt antistof, der er specifikt for leukoregulincelleoverfladereceptorer, og fremgangsmåde til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og prøve for tumorcellefølsomhed under anvendelse af det monoklonale antistof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK562285A DK170781B1 (da) 1984-04-13 1985-12-04 Human leukoregulin og biologisk aktive underenheder deraf, fremgangsmåde til fremstilling og til oprensning af human leukoregulin, biologisk aktivt materiale indeholdende human leukoregulin samt celle, som producerer human leukoregulin

Country Status (9)

Country Link
EP (1) EP0179127B1 (da)
JP (2) JP2562014B2 (da)
AT (1) ATE48617T1 (da)
AU (2) AU592529B2 (da)
DE (1) DE3574710D1 (da)
DK (2) DK170781B1 (da)
FI (1) FI85867C (da)
NO (1) NO170423C (da)
WO (1) WO1985004662A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592529B2 (en) * 1984-04-13 1990-01-18 Litton Bionetics, Inc. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6087166A (en) 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
US20080118979A1 (en) 2006-05-15 2008-05-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
ES2931180T3 (es) 2011-05-19 2022-12-27 Fund Publica Andaluza Progreso Y Salud Sistema de tipo Tet-on lentivírico de promotor dual muy inducible

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4403035A (en) * 1981-06-19 1983-09-06 Regents Of The University Of Minnesota In vitro DNA-Protein viral assembly and gene cloning system
DE3138230A1 (de) * 1981-09-25 1983-04-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von makrophagen- aktivierungsfaktor (maf)
JPS6011889B2 (ja) * 1981-10-28 1985-03-28 電気化学工業株式会社 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
AU592529B2 (en) * 1984-04-13 1990-01-18 Litton Bionetics, Inc. Leukoregulin, an antitumor lymphokine, and its therapeutic uses

Also Published As

Publication number Publication date
DK170781B1 (da) 1996-01-15
JPH06253832A (ja) 1994-09-13
DK562285D0 (da) 1985-12-04
AU592529B2 (en) 1990-01-18
DE3574710D1 (de) 1990-01-18
DK562285A (da) 1985-12-04
DK98692A (da) 1992-08-04
DK170423B1 (da) 1995-08-28
EP0179127A4 (en) 1986-08-21
JPS61501853A (ja) 1986-08-28
EP0179127B1 (en) 1989-12-13
FI854803A (fi) 1985-12-04
AU4234185A (en) 1985-11-01
WO1985004662A1 (en) 1985-10-24
FI85867B (fi) 1992-02-28
NO854994L (no) 1985-12-12
NO170423C (no) 1992-10-14
JP2562014B2 (ja) 1996-12-11
FI85867C (fi) 1992-06-10
EP0179127A1 (en) 1986-04-30
FI854803A0 (fi) 1985-12-04
JP2564245B2 (ja) 1996-12-18
ATE48617T1 (de) 1989-12-15
NO170423B (no) 1992-07-06
AU5365390A (en) 1990-09-20
AU641386B2 (en) 1993-09-23

Similar Documents

Publication Publication Date Title
DK0702563T3 (da) Sammensætninger og fremgangsmåder til behandling af cancer og hyperproliferative sygdomme
HU9403784D0 (en) Immunoconjugates
ES2154354T3 (es) Ligandos tie-2, metodos para obtenerlos y sus usos.
Hopkins et al. High-frequency cotransfer of the transformed phenotype and a tumor-specific transplantation antigen by DNA from the 3-methylcholanthrene-induced Meth A sarcoma of BALB/c mice.
DK98692D0 (da) Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof
Kudlow et al. Inability of anti-epidermal growth factor receptor monoclonal antibody to block “autocrine” growth stimulation in transforming growth factor-secreting melanoma cells.
Troppmair et al. An altered v-raf is required in addition to v-myc in J3V1 virus for acceleration of murine plasmacytomagenesis.
Tagliaferri et al. Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH3T3 cells transfected with Ha-MuSV DNA
CN108884138A (zh) 去免疫的治疗性组合物和方法
ES8600518A1 (es) Metodo in vitro para detectar un estado maligno en un paciente humano.
AU2001220255A1 (en) Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector
Raška Jr et al. Double-stranded DNA binding of adenovirus type 12 tumor antigen
EP1006125B1 (en) Goat epididymal forward motility protein
Choi et al. Production and characterization of monoclonal antibodies to bovine brain GABA transaminase
DE58907987D1 (de) Pyruvatkinase-isoenzyme typ m2 (tumor m2-pk) - spezifische antikörper/verfahren zu deren herstellung und deren verwendung.
Matsumoto et al. Stimulation of bone collagenase synthesis by mouse fibrosarcoma in resorbing bone in vitro culture
SU1173990A1 (ru) Способ определени активности процесса костеобразовани
JPH03505575A (ja) 幹細胞阻害剤
Greenberger et al. Biochemical Purification of a CSF-1 like Molecule Released during Malignant Transformation of IL-3 Dependent Hematopoietic Progenitor cell lines Cocultivated with Gamma Irradiated Clonal Marrow Stromal cell lines
LINES et al. Department Of Radiation Oncology, University Of Massachusetts Medical Center, Worcester, MA 01655 Cocultivation of IL-3 dependent hematopoietic progenitor cell line FDC-P1JL26 with 5000 cGy irradiated clonal bone marrow
Herbyn et al. Inhibition of Growth of Colorectal Carcinoma in Nude Mice by Monoclonal Antibody1
Brysk et al. Calcium-mediated changes in related malignant and nonmalignant mouse epidermal cell lines
Behzadian GENETICS AND IMMUNOLOGICAL CHARACTERIZATION OF EPIDERMAL GROWTH FACTOR RECEPTORS AND THEIR RELATION TO THE MECHANISM OF CELL GROWTH CONTROL (MONOCLONAL ANTIBODY, TUMOR, RICIN TOXIN)
Ball Leghemoglobin biosynthesis in soybean root nodules
JPS57202287A (en) Cultivation and preparation of urokinase by it

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed